Munich, Germany

Dirk Schenk

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Ratiopharm Gmbh, Teva Pharmaceuticals International Gmbh. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dirk Schenk. Retrieved from https://idiyas.com/inventor/dirk-schenk-d86xoiv5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dirk Schenk - Innovative Inventor from Munich

Introduction: Dirk Schenk is a renowned inventor hailing from Munich, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Dirk Schenk holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his versatility and forward-thinking approach.

Career Highlights: With over two decades of experience in the innovation industry, Dirk Schenk has worked with leading research institutions and multinational companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Dirk Schenk has collaborated with top engineers, scientists, and designers to bring his ideas to life, fostering a culture of creativity and excellence in every project he undertakes.

Conclusion: Dirk Schenk's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…